HMGB1 and cancer: The study suggested that New FP therapy, a locoregional therapy with high local control potential, might have promoted step 1, as indicated by increased MHC-I-positive cells and serum HMGB1 and accelerated rotation of the cancer-immunity cycle, resulting in long PFS and OS.6